Form D · Pharmaceuticals

Sujana Biotech, LLC

Cleveland, OH · CIK 0001638929

Offering snapshot reported Apr 29, 2016 · SEC filing

Reported sold
$800K
Offering amount: $5M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 20, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$400K$800KMay 4, 2015: $800,000.00May 4, 2015Apr 29, 2016: $800,000.00Apr 29, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 29, 2016Amendment$800,000$0vs May 4, 20154SEC filing
May 4, 2015Initial$800,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-239092

Source: Form D, filed Apr 29, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Baiju Shah Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
20600 Chagrin Blvd. Suite 210
Cleveland, OH, 44122